Free Trial
Tada emoji MarketBeat All Access — Now Just $5.00 for 5 Weeks

BerGenBio ASA (BRRGF) News Today

BerGenBio ASA logo
$250.00 0.00 (0.00%)
As of 08/22/2025
Compare

BRRGF Latest News

BerGenBio ASA Merges with Oncoinvent to Boost Cancer Innovation
August 21 at 5:31 AM  |  msn.comhttps://www.msn.com/en-us/money/savingandinvesting/bergenbio-asa-merges-with-oncoinvent-to-boost-cancer-innovation/ar-AA1KVDAe
BerGenBio ASA Announces Strategic Merger with Oncoinvent ASA
August 20 at 12:31 AM  |  msn.comhttps://www.msn.com/en-us/money/savingandinvesting/bergenbio-asa-announces-strategic-merger-with-oncoinvent-asa/ar-AA1KRrOd
BerGenBio ASA Announces NOK 130 Million Rights Issue Post-Merger
August 5, 2025  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/bergenbio-asa-announces-nok-130-million-rights-issue-post-merger-3?utm_source=marketbeat.com&utm_medium=referral
BerGenBio ASA Announces Virtual Extraordinary General Meeting
July 3, 2025  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/bergenbio-asa-announces-virtual-extraordinary-general-meeting?utm_source=marketbeat.com&utm_medium=referral
BerGenBio and Oncoinvent, a rising innovator in radiopharmaceutical cancer therapies, announce proposed merger and a fully underwritten rights issue
June 30, 2025  |  finance.yahoo.comhttps://finance.yahoo.com/news/bergenbio-oncoinvent-rising-innovator-radiopharmaceutical-202800259.html
BerGenBio ASA Announces NOK 130 Million Rights Issue Post-Merger
June 30, 2025  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/bergenbio-asa-announces-nok-130-million-rights-issue-post-merger-2?utm_source=marketbeat.com&utm_medium=referral
BerGenBio ASA Approves Board Resolutions in Annual Meeting
June 26, 2025  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/bergenbio-asa-approves-board-resolutions-in-annual-meeting?utm_source=marketbeat.com&utm_medium=referral
BerGenBio Continues Strategic Review and Ends Bemcentinib Development
June 3, 2025  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/bergenbio-continues-strategic-review-and-ends-bemcentinib-development?utm_source=marketbeat.com&utm_medium=referral
BerGenBio ASA Announces Virtual Annual General Meeting
June 3, 2025  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/bergenbio-asa-announces-virtual-annual-general-meeting?utm_source=marketbeat.com&utm_medium=referral
BerGenBio’s Bemcentinib Shows Promise in AML Treatment
March 26, 2025  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/bergenbios-bemcentinib-shows-promise-in-aml-treatment?utm_source=marketbeat.com&utm_medium=referral
BerGenBio ASA Discontinues Lung Cancer Study, Explores Strategic Options
February 25, 2025  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/bergenbio-asa-discontinues-lung-cancer-study-explores-strategic-options?utm_source=marketbeat.com&utm_medium=referral
BerGenBio ASA Receives ‘Buy’ Rating Amid Strategic Progress with Bemcentinib Trial Targeting NSCLC Treatment
January 8, 2025  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/bergenbio-asa-receives-buy-rating-amid-strategic-progress-with-bemcentinib-trial-targeting-nsclc-treatment-1034201402
BerGenBio Initiates Clinical Trial for Promising Lung Cancer Treatment
January 7, 2025  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/bergenbio-initiates-clinical-trial-for-promising-lung-cancer-treatment?utm_source=marketbeat.com&utm_medium=referral
Promising Advancements in BerGenBio’s Bemcentinib Trial for STK11 Mutations in NSCLC Underpin Buy Rating
December 24, 2024  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/promising-advancements-in-bergenbio-s-bemcentinib-trial-for-stk11-mutations-in-nsclc-underpin-buy-rating-1034167647
BerGenBio Highlights Clinical Progress and Strategy
November 26, 2024  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/bergenbio-highlights-clinical-progress-and-strategy?utm_source=marketbeat.com&utm_medium=referral
BerGenBio ASA Appoints New CEO to Lead Growth
November 21, 2024  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/bergenbio-asa-appoints-new-ceo-to-lead-growth-1034044797
BerGenBio Appoints Olav Hellebø as CEO
November 20, 2024  |  uk.finance.yahoo.comhttps://uk.finance.yahoo.com/news/bergenbio-appoints-olav-helleb-ceo-203100229.html
BerGenBio Third Quarter Results 2024
November 13, 2024  |  finance.yahoo.comhttps://finance.yahoo.com/news/bergenbio-third-quarter-results-2024-061200433.html
Buy Rating Affirmed: Promising Safety and Efficacy Signals in BerGenBio’s NSCLC Treatment Study
October 8, 2024  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/buy-rating-affirmed-promising-safety-and-efficacy-signals-in-bergenbio-s-nsclc-treatment-study-1033825758
Buy Rating Affirmed for BerGenBio ASA on Clinical and Strategic Advancements
August 23, 2024  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/buy-rating-affirmed-for-bergenbio-asa-on-clinical-and-strategic-advancements-1033715746
BerGenBio ASA (7BG0.F)
August 22, 2024  |  uk.finance.yahoo.comhttps://uk.finance.yahoo.com/quote/7BG0.F/news/
BerGenBio First Quarter Results 2024: Advancing to the Next Stage of Development
May 29, 2024  |  finance.yahoo.comhttps://finance.yahoo.com/news/bergenbio-first-quarter-results-2024-053000658.html?.tsrc=rss
BerGenBio Announces NCI Clinical Collaboration with UT Health San Antonio and Sobi®
May 28, 2024  |  finance.yahoo.comhttps://finance.yahoo.com/news/bergenbio-announces-nci-clinical-collaboration-133700173.html?.tsrc=rss
BerGenBio Announces Initiation of Phase 2a in First Line Non-Small Lung Cancer Patients with a STK11 mutation
March 20, 2024  |  finance.yahoo.comhttps://finance.yahoo.com/news/bergenbio-announces-initiation-phase-2a-181400841.html?.tsrc=rss
BerGenBio Announces New Preclinical Data Indicating Broadened Potential for Bemcentinib to Treat Severe Respiratory Infections
February 7, 2024  |  finance.yahoo.comhttps://finance.yahoo.com/news/bergenbio-announces-preclinical-data-indicating-111900261.html
Gram Car Carriers Asa Share Price (GCC.OL)
January 31, 2024  |  lse.co.ukhttps://www.lse.co.uk/SharePrice.html?shareprice=GCC.OL
BerGenBio ASA (BRRGF) stock historical prices & data – Yahoo Finance
December 2, 2023  |  sg.finance.yahoo.comhttps://sg.finance.yahoo.com/quote/BRRGF/history/
BerGenBio ASA BGBIO
November 18, 2023  |  morningstar.comM
BerGenBio Reports Third Quarter 2023 Financial Results
November 14, 2023  |  finance.yahoo.comhttps://finance.yahoo.com/news/bergenbio-reports-third-quarter-2023-062200039.html?.tsrc=rss
BerGenBio Announces Data from Biomarker Analyses in 2L NSCLC
November 6, 2023  |  finance.yahoo.comhttps://finance.yahoo.com/news/bergenbio-announces-data-biomarker-analyses-061600266.html?.tsrc=rss
BerGenBio Announces Poster Presentation at Upcoming SITC Meeting
October 31, 2023  |  finance.yahoo.comhttps://finance.yahoo.com/news/bergenbio-announces-poster-presentation-upcoming-133700668.html?.tsrc=rss
New Data on BerGenBio's Selective AXL Inhibitor Bemcentinib Released Today at 2023 ESMO Meeting
October 23, 2023  |  finance.yahoo.comhttps://finance.yahoo.com/news/data-bergenbios-selective-axl-inhibitor-054500210.html?.tsrc=rss
Additional data on BerGenBio's selective AXL inhibitor bemcentinib to be presented at the 2023 ESMO meeting
October 16, 2023  |  finance.yahoo.comhttps://finance.yahoo.com/news/additional-data-bergenbios-selective-axl-052100022.html?.tsrc=rss
H.C. Wainwright Reaffirms Their Buy Rating on BerGenBio AS (BRRGF)
August 23, 2023  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/h-c-wainwright-reaffirms-their-buy-rating-on-bergenbio-as-brrgf-1032577406
BerGenBio announces clinical data presentations highlighting the activity of its selective AXL inhibitor bemcentinib in Non-Small Cell Lung Cancer
August 22, 2023  |  finance.yahoo.comhttps://finance.yahoo.com/news/bergenbio-announces-clinical-data-presentations-085000151.html?.tsrc=rss
Coronation concert ballot misleading, says regulator ASA
August 15, 2023  |  bbc.co.ukhttps://www.bbc.co.uk/news/entertainment-arts-66315390
BerGenBio ASA: Approval and publication of prospectus for the preferential Rights Issue
May 26, 2023  |  finance.yahoo.comhttps://finance.yahoo.com/news/bergenbio-asa-approval-publication-prospectus-130700981.html?.tsrc=rss
BerGenBio AS (BRRGF) Gets a Buy from H.C. Wainwright
May 16, 2023  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/bergenbio-as-brrgf-gets-a-buy-from-h-c-wainwright-1032330608
BerGenBio ASA: Proposed partially underwritten rights issue
April 25, 2023  |  finance.yahoo.comhttps://finance.yahoo.com/news/bergenbio-asa-proposed-partially-underwritten-162600025.html?.tsrc=rss
BerGenBio Announces First Patient Dosed in Phase 1b/2a Trial Evaluating Bemcentinib in 1st Line Non-Small Cell Lung Cancer with STK11 Mutations
March 9, 2023  |  finance.yahoo.comhttps://finance.yahoo.com/news/bergenbio-announces-first-patient-dosed-102200986.html?.tsrc=rss
BerGenBio ASA: BerGenBio Announces Positive Data From Phase 2 Trial of Bemcentinib in Combination with Pembrolizumab in 2L+ NSCLC Patients
February 17, 2023  |  finanznachrichten.dehttps://www.finanznachrichten.de/nachrichten-2023-02/58322463-bergenbio-asa-bergenbio-announces-positive-data-from-phase-2-trial-of-bemcentinib-in-combination-with-pembrolizumab-in-2l-nsclc-patients-008.htm
BerGenBio Reports Fourth Quarter 2022 Financial Results and Provides Business Update
February 16, 2023  |  finance.yahoo.comhttps://finance.yahoo.com/news/bergenbio-reports-fourth-quarter-2022-063200550.html?.tsrc=rss
BerGenBio Announces Positive Data From Phase 2 Trial of Bemcentinib in Combination with Pembrolizumab in 2L+ NSCLC Patients
February 15, 2023  |  finance.yahoo.comhttps://finance.yahoo.com/news/bergenbio-announces-positive-data-phase-163500078.html?.tsrc=rss
BerGenBio reports third quarter 2022 financial results and provides business update
November 15, 2022  |  finance.yahoo.comhttps://finance.yahoo.com/news/bergenbio-reports-third-quarter-2022-061000122.html?.tsrc=rss
BerGenBio ASA Secures NOK 100 million Shareholder Loan Facility from Meteva AS
October 25, 2022  |  prnewswire.comhttps://www.prnewswire.com:443/news-releases/bergenbio-asa-secures-nok-100-million-shareholder-loan-facility-from-meteva-as-301658046.html
BerGenBio Announces Initiation of Phase 1b/2a Trial Evaluating Bemcentinib in 1st line Non-Small Cell Lung Cancer Patients Harboring STK11 Mutations
October 11, 2022  |  finance.yahoo.comhttps://finance.yahoo.com/news/bergenbio-announces-initiation-phase-1b-053600734.html?.tsrc=rss
BERGENBIO ANNOUCES FIRST PATIENT RANDOMIZED IN BEMCENTINIB TRIAL IN EU-SOLIDACT PLATFORM FOR HOSPITALIZED COVID-19 PATIENTS
September 27, 2022  |  finance.yahoo.comhttps://finance.yahoo.com/news/bergenbio-annouces-first-patient-randomized-133100257.html?.tsrc=rss
BGBIO.OL - Bergenbio ASA | Stock Price & Latest News | Reuters
September 10, 2022  |  reuters.comhttps://www.reuters.com/markets/companies/BGBIO.OL
BerGenBio reports second quarter and half year 2022 financial results and provides business update
August 23, 2022  |  finance.yahoo.comhttps://finance.yahoo.com/news/bergenbio-reports-second-quarter-half-053600024.html?.tsrc=rss
BerGenBio strengthens its leadership team with appointment of Cristina Oliva as Chief Medical Officer
April 11, 2022  |  finance.yahoo.comhttps://finance.yahoo.com/news/bergenbio-strengthens-leadership-team-appointment-051200362.html?.tsrc=rss
Get BerGenBio ASA News Delivered to You Automatically

Sign up to receive the latest news and ratings for BRRGF and its competitors with MarketBeat's FREE daily newsletter.

BRRGF Media Mentions By Week

BRRGF Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

BRRGF
News Sentiment
▼
-0.40

0.66
▲
Average
Medical
News Sentiment

BRRGF News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

BRRGF Articles
This Week
▼
2

0
▲
BRRGF Articles
Average Week

Get BerGenBio ASA News Delivered to You Automatically

Sign up to receive the latest news and ratings for BRRGF and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

Related Companies
Headlines Tools

This page (OTCMKTS:BRRGF) was last updated on 8/23/2025 by MarketBeat.com Staff
From Our Partners
Musk’s Project Colossus could mint millionaires
I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...
Brownstone Research | Sponsoredtc pixel
Alex’s “Next Magnificent Seven” stocks
The original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...
The Oxford Club | Sponsoredtc pixel
Elon’s Secret Social Security Bombshell
To All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...
Banyan Hill Publishing | Sponsoredtc pixel
The $7 company helping Nvidia build the world’s first trillion-dollar robot …
Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...
Weiss Ratings | Sponsoredtc pixel
INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.
Traders Agency | Sponsoredtc pixel
Trump set to Boost Social Security Checks by 400%?
If you're collecting or planning to collect social security... You should see this presentation about Presi...
InvestorPlace | Sponsoredtc pixel
The Trump Dump is starting; Get out of stocks now?
The first 365 days of the Trump presidency… Will be the best time to get rich in American history.
Paradigm Press | Sponsoredtc pixel
Critical AI announcement set to ignite AI 2.0
I just put together an urgent new presentation that you need to see right away. In short: I believe we are...
Timothy Sykes | Sponsoredtc pixel